« Previous
Next »
Titles
- E11(R1) addendum: clinical investigation of medicinal products in the pediatric population1
- E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs--questions and answers (R3)1
- E17 general principles for planning and design of multiregional clinical trials1
- E18 genomic sampling and management of genomic data1
- E6(R2) good clinical practice: integrated addendum to ICH E6(R1)1
- Early learning and child care: agencies have helped address fragmentation and overlap through improved coordination : report to the Chairwoman, Committee on Education and the Workforce, House of Representatives1
- Early learning and child care: overview of federal investment and agency coordination : testimony before the Subcommittee on Early Childhood, Elementary, and Secondary Education, Committee on Education and the Workforce, House of Representatives1
- Easing the stigma of public coverage: workers with health coverage at their jobs get significant government aid too1
- Effect of a price transparency intervention in the electronic health record on clinician ordering of inpatient laboratory tests1
- Effects of Medicare Advantage enrollment on beneficiary risk scores1
- Elagolix for treating endometriosis: final evidence report1
- Elemental impurities in drug products1
- Eligibility and enrollment: current status and challenges1
- Eliminating the ACA's individual mandate: how would California fare?1
- Emergency care1
- Emergency use authorization of medical products and related authorities: guidance for industry and other stakeholders1
- Emerging infectious diseases: actions needed to ensure improved response to Zika virus disease outbreaks : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives1
- Emicizumab for hemophilia A with inhibitors: effectiveness and value : final evidence report1
- Employment of people ages 55 to 791
- Enabling sustainable investment in social interventions: a review of Medicaid managed care rate-setting tools1